- Foster City CA, US Scott E. Lazerwith - San Francisco CA, US Hyung-Jung Pyun - Fremont CA, US Manoj C. Desai - Foster City CA, US Teresa Alejandra Trejo - Foster City CA, US Elizabeth Bacon - Foster City CA, US Jeromy J. Cottell - Foster City CA, US Zhenhong R. Cai - Palo Alto CA, US Philip Anthony Morganelli - Foster City CA, US Mingzhe Ji - Union City CA, US James G. Taylor - Foster City CA, US Xiaowu Chen - Hillsborough CA, US Michael R. Mish - Foster City CA, US
International Classification:
C07D 498/14 A61K 31/537 A61K 31/553 A61K 45/06
Abstract:
Compounds for use in the treatment of human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following Formula (I):including stereoisomers and pharmaceutically acceptable salts thereof, wherein R, X, W, Y, Y, Z, and Zare as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
Substituted 1,2,3,4,6,8,12,12A-Octahydro-1,4-Methanodipyrido[1,2-A:1',2'-D]Pyrazines And Methods For Treating Viral Infections
- Foster City CA, US Scott E. Lazerwith - San Francisco CA, US Hyung-Jung Pyun - Fremont CA, US Manoj C. Desai - Foster City CA, US Teresa Alejandra Trejo Martin - Foster City CA, US Elizabeth Bacon - Foster City CA, US Jeromy J. Cottell - Foster City CA, US Zhenhong R. Cai - Palo Alto CA, US Philip Anthony Morganelli - Foster City CA, US Mingzhe Ji - Union City CA, US James G. Taylor - Foster City CA, US Xiaowu Chen - Hillsborough CA, US Michael R. Mish - Foster City CA, US
International Classification:
C07D 487/14
Abstract:
Compounds for use in the treatment of human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following Formula (I):including stereoisomers and pharmaceutically acceptable salts thereof, wherein R, X, W, Y, Y, Z, and Zare as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use
- Foster City CA, US Scott E. LAZERWITH - San Francisco CA, US Teresa Alejandra TREJO MARTIN - Union City CA, US Elizabeth M. BACON - Burlingame CA, US Jeromy J. COTTELL - Redwood City CA, US Zhenhong R. CAI - Palo Alto CA, US Hyung-Jung PYUN - Fremont CA, US Philip Anthony MORGANELLI - Oakland CA, US Mingzhe JI - Union City CA, US James G. TAYLOR - San Mateo CA, US Xiaowu CHEN - Hillsborough CA, US Michael R. MISH - Foster City CA, US Manoj C. DESAI - Pleasant Hill CA, US
Compounds for use in the treatment of human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following Formula (I):including stereoisomers and pharmaceutically acceptable salts thereof, wherein R, X, W, Y, Y, Z, and Zare as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.